Morgan Stanley
Global financial services; wealth management
AI Enablement Lead - Vice President, Technology Management
About the job
- 5-10+ years of experience in financial services, investment research, fintech, or related fields.
- Strong understanding of financial markets and research workflows.
- Hands-on experience with generative artificial intelligence, prompt engineering, and Python.
- Proven team leadership, product/project management, and stakeholder management experience.
- Ability to bridge business, technology, and governance functions while driving enterprise artificial intelligence initiatives.
- Execute and shape the artificial intelligence adoption strategy for Global Research by identifying and prioritizing high-value use cases and building a roadmap that improves analyst workflows, productivity, and research processes.
- Define the optimal balance of centrally developed tools versus custom solutions and enable teams with ready-to-deploy artificial intelligence assets.
- Lead the artificial intelligence Enablement team of five Prompt Engineers and four Annotators by setting priorities, managing delivery, developing talent, and driving best practices across generative artificial intelligence initiatives.
- Translate Research needs into artificial intelligence solutions by partnering with analysts, technology, data, and product teams to design, deploy, evaluate, and support scalable artificial intelligence tools, prompts, and workflows.
- Drive artificial intelligence governance and compliance, ensuring that all artificial intelligence solutions meet legal, risk, model governance, information security, and regulatory requirements.
- Serve as the artificial intelligence subject matter expert for Research by evaluating emerging artificial intelligence technologies, optimizing platform and model usage, and advising stakeholders on effective applications of generative artificial intelligence.
- Lead training, change management, and measurement efforts through education, best practices, key performance indicator tracking, user feedback, and reporting on business impact to senior leadership.
About the company
Morgan Stanley is a global financial services firm offering investment banking, securities, wealth management, and investment management services to individuals, families, institutions, and governments. It helps clients raise, manage, and distribute capital through advisory services, asset management, trading, and financing activities, with revenue from advisory fees, asset management fees, trading commissions, and interest income. The company differentiates itself through its large, worldwide platform that provides a full suite of services across markets and client segments, a focus on client needs and long-term relationships, and a strong emphasis on institutional expertise and capital markets capabilities. Its goal is to help clients achieve their financial objectives by delivering tailored financial solutions and maintaining enduring client partnerships.
Company Size
10,001+
Company Stage
IPO
Headquarters
New York City, New York
Founded
1935
Get referred to Morgan Stanley
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 2026 revenue reached $21.3 billion, with EPS of $3.46 and ROTCE 26.6%.
- Wealth Management added $148 billion net new assets in Q2 2026, boosting recurring fees.
- Morgan Stanley is booking more capital-markets wins, including Fortis's September 2026 note offering.
What critics are saying
- March 2026 layoffs cut 2,500 jobs, signaling continued cost pressure and restructuring.
- Western Asset settled SEC allegations on June 5, 2026 with a $100 million penalty.
- Private-equity-linked Liquidity Asset Line complaints in 2026 expose suitability and reputational risk.
What makes Morgan Stanley unique
- Morgan Stanley hit $10 trillion client assets in July 2026, a rare wealth-management scale.
- Its July 2026 wealth business posted $8.9 billion revenue and 30.5% pretax margin.
- The bank combines elite advisory, trading, and wealth platforms across 83,000 employees.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Hybrid Work Options
401(k) Retirement Plan
401(k) Company Match
Mental Health Support
Wellness Program
Company News
Inclusive of Prior Hedging Activity, the All-In Interest Rate of the Notes is 5.36% ...
Capital One Financial has completed a €1.5 billion public offering of fixed-to-floating rate senior notes. The offering consists of two tranches maturing in 2032 and 2037, with coupons of 4.326% and 4.832% respectively. The notes were sold through an underwriting syndicate including Barclays Bank, Deutsche Bank, Goldman Sachs, Morgan Stanley and Capital One Securities. They were issued under existing senior indenture arrangements and registered under the Securities Act of 1933. Capital One entered into a paying agency agreement with The Bank of New York Mellon's London branch to administer payments on the euro-denominated securities. The transaction provides Capital One with continued access to international capital markets and diversifies its funding base through long-dated euro senior notes.
Disc Medicine, a clinical-stage biopharmaceutical company focused on treatments for hematologic diseases, has priced an upsized public offering of common stock and pre-funded warrants. The company is selling 2,595,919 shares of common stock at $49.00 per share and pre-funded warrants to purchase 204,081 shares at $48.9999 per warrant. The offering is expected to generate gross proceeds of $137.2 million before expenses. Disc has also granted underwriters a 30-day option to purchase an additional 420,000 shares. The offering is scheduled to close on 16 June 2023. Disc intends to use the proceeds to fund research and clinical development of its product candidates, as well as for working capital and general corporate purposes. Morgan Stanley, SVB Securities, Stifel and BMO Capital Markets are acting as joint book-running managers.
First Citizens BancShares has raised $300 million through a public offering of perpetual preferred stock. The bank issued 300,000 depositary shares at $1,000 each, with net proceeds of approximately $297 million after underwriting costs. The Series F preferred stock pays a fixed 7.5% annual dividend until September 2031, after which it converts to a floating rate tied to the five-year Treasury rate plus 2.894%. The stock is perpetual and non-cumulative, with no required redemption date. The offering adds $300 million in Tier 1 capital but creates a senior claim ahead of common shareholders on dividends and liquidation. If First Citizens misses a full quarterly dividend, it generally cannot pay dividends on or buy back common stock during the next period. The underwriting syndicate included Morgan Stanley, BofA Securities, J.P. Morgan Securities, and Wells Fargo Securities as lead bookrunners.
Sidley represented American Healthcare REIT, Inc. (AHR), a publicly registered healthcare REIT, in AHR’s US$819 million forward public offering of 15,237,500 shares of common stock, which includes 1,987,500 shares issued pursuant to the underwriter’s full exercise of its option to purchase additional shares. In connection with the offering, AHR entered into forward sale agreements with Morgan Stanley & Co. LLC, Citibank, N.A., and KeyBanc Capital Markets Inc. (or affiliates thereof) with respect to the shares being offered.